{"id":741,"date":"2023-07-05T15:45:50","date_gmt":"2023-07-05T07:45:50","guid":{"rendered":"http:\/\/longmed-medical.com\/?p=741"},"modified":"2023-12-21T14:17:16","modified_gmt":"2023-12-21T06:17:16","slug":"zip-stitch-longmed-wound-closure-device","status":"publish","type":"post","link":"https:\/\/longmed-medical.com\/is\/rennilas-med-longum-saralokabunadi\/","title":{"rendered":"Zip Stitch Longmed Wound Device Randomized Study"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Zip Stitch Longmed Wound Device Randomized Study<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Slembira\u00f0a\u00f0 ranns\u00f3kn \u00e1 n\u00fdju \u00f3\u00edfarandi rennil\u00e1ss-h\u00fa\u00f0lokunarb\u00fana\u00f0i til notkunar eftir me\u00f0f\u00e6ddar hjartaa\u00f0ger\u00f0ir<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Yuki Tanaka, MD, Takashi Miyamoto, MD, PhD, Yuji Naito, MD, PhD, <\/b><\/strong><\/p>

Shuichi Yoshitake, l\u00e6knir, Akihiro Sasahara, l\u00e6knir og Kagami Miyaji, l\u00e6knir, PhD <\/b><\/strong><\/p>

Hjarta- og \u00e6\u00f0askur\u00f0deild, Gunma barnal\u00e6kningami\u00f0st\u00f6\u00f0in, Shibukawa; og hjarta- og \u00e6\u00f0askur\u00f0deild,<\/p>

Kitasato h\u00e1sk\u00f3lasj\u00fakrah\u00fasi\u00f0, Sagamihara, Japan<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Longmed\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Bakgrunnur:<\/p>

Vi\u00f0 tilkynnum um n\u00fdjan Zip Stitch Longmed sem er ekki \u00edfarandi s\u00e1ralokunarb\u00fana\u00f0<\/a> (ZheJiang Longmed Medical Technology Co., Ltd.). \u00deetta t\u00e6ki er tali\u00f0 hafa g\u00f3\u00f0a snyrtiv\u00f6ru\u00e1rangur eftir a\u00f0ger\u00f0ir og styttir skur\u00f0a\u00f0ger\u00f0art\u00edma. \u00cd \u00feessari ranns\u00f3kn var h\u00fa\u00f0lokun me\u00f0 lokunarb\u00fana\u00f0i borin saman vi\u00f0 sauma undir h\u00fa\u00f0 og notagildi og \u00f6ryggi \u00feessa n\u00fdja t\u00e6kis meti\u00f0.<\/p>

A\u00f0fer\u00f0ir:<\/p>

\u00deetta var framb\u00e6rileg, slembir\u00f6\u00f0u\u00f0 ranns\u00f3kn \u00e1 214 sj\u00faklingum sem gengust undir hjartaa\u00f0ger\u00f0ir me\u00f0 mi\u00f0gildi sternot\u00f3m fr\u00e1 j\u00fan\u00ed 2014 til desember 2015. Hj\u00e1 136 sj\u00faklingum var \u00feetta fyrsti a\u00f0ger\u00f0ah\u00f3purinn, \u00fear af 71 sj\u00faklingur sem gekkst undir s\u00e1ralokunarb\u00fana\u00f0 (Lokunarh\u00f3pur) og 65 sj\u00faklingar. sj\u00faklingar f\u00f3ru \u00ed sauma undir h\u00fa\u00f0 (saumh\u00f3pur). Hj\u00e1 78 sj\u00faklingum var \u00feetta endura\u00f0ger\u00f0ah\u00f3pur, \u00fear af voru 42 sj\u00faklingar \u00ed lokunarh\u00f3pnum og 36 sj\u00faklingar \u00ed saumah\u00f3pnum. Snyrtifr\u00e6\u00f0ilegar ni\u00f0urst\u00f6\u00f0ur me\u00f0 Vancouver Scar Scale voru metnar s\u00e9rstaklega \u00ed fyrsta a\u00f0ger\u00f0ah\u00f3pnum og endura\u00f0ger\u00f0ah\u00f3pnum.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Ni\u00f0urst\u00f6\u00f0ur:<\/p>

Markt\u00e6kur munur var \u00e1 heildarskori Vancouver \u00f6rkvar\u00f0a milli fyrsta a\u00f0ger\u00f0ah\u00f3psins (p < 0,001) og endura\u00f0ger\u00f0ah\u00f3psins (p [0,007). Lokunart\u00edmi h\u00fa\u00f0arinnar var markt\u00e6kt styttri \u00ed lokunarh\u00f3pnum en \u00ed saumah\u00f3pnum (113,0 \u00b1 9,1 sek\u00fandur \u00e1 m\u00f3ti 375,9 \u00b1 60,2 sek\u00fandum, p < 0,001). Enginn markt\u00e6kur munur fannst var\u00f0andi t\u00ed\u00f0ni s\u00fdkingar \u00e1 skur\u00f0sta\u00f0 milli h\u00f3panna. Fylgikvillar sem einkenndu \u00feetta t\u00e6ki voru me\u00f0al annars aflitun \u00e1 h\u00fa\u00f0(0.9%), h\u00fa\u00f0\u00feekju (0.9%) og h\u00fa\u00f0fl\u00f6gnun t\u00e6kisins (1.8%); \u00fe\u00f3 komu ekki fram alvarlegir fylgikvillar.<\/span><\/p>\n

<\/p>\n

\u00c1lyktanir:<\/p>

\u00cd me\u00f0f\u00e6ddum hjartaa\u00f0ger\u00f0um me\u00f0 mi\u00f0gildi sternotomy var s\u00e1rlokunarb\u00fana\u00f0urinn an fr\u00e1b\u00e6rt val til a\u00f0 b\u00e6ta snyrtiv\u00f6ru\u00fatliti\u00f0 og draga \u00far lokunart\u00edma s\u00e1rsins. Auk \u00feess reyndist \u00feetta t\u00e6ki sem h\u00e6gt var a\u00f0 nota \u00e1 \u00f6ruggan h\u00e1tt.<\/span><\/p>\n

(Ann Thorac Surg 2016;102:1368\u201374) 2016 af The Society of Thoracic Surgeons<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

S\u00fdkingar \u00e1 skur\u00f0sta\u00f0 og ofst\u00e6kkun \u00f6r eru helstu fylgikvillar s\u00e1ra eftir skur\u00f0a\u00f0ger\u00f0, og \u00feeir geta stundum komi\u00f0 fram eftir hjarta- og \u00e6\u00f0aa\u00f0ger\u00f0ir [1\u20133]. Tilkynnt hefur veri\u00f0 um notkun nokkurra h\u00fa\u00f0lokunart\u00e6kja, svo sem s\u00fdan\u00f3kr\u00fdlatl\u00edms og skur\u00f0a\u00f0ger\u00f0ahefta [4-6] og s\u00fdnt hefur veri\u00f0 fram \u00e1 a\u00f0 \u00feessi t\u00e6ki geta haft g\u00f3\u00f0a m\u00f6guleika til a\u00f0 stytta h\u00fa\u00f0lokunart\u00edma, b\u00e6ta snyrtiv\u00f6ru\u00fatlit og l\u00e6kka s\u00fdkingart\u00ed\u00f0ni . S\u00e1rlokunarb\u00fana\u00f0urinn (ZheJiang Longmed Medical Technology Co., Ltd.,) er n\u00fdtt, ekki \u00edfarandi lokah\u00fa\u00f0lokunart\u00e6ki sem dregur \u00far m\u00f6guleikum\u00a0fyrir fylgikvilla s\u00e1ra [7, 8].<\/span><\/p>

\u00der\u00f3unarhugmyndin me\u00f0 Zip Stitch Longmed s\u00e1ralokunarb\u00fana\u00f0i var a\u00f0 stytta lokunart\u00edma h\u00fa\u00f0arinnar og koma \u00ed veg fyrir ofst\u00e6kkun \u00f6r eftir a\u00f0ger\u00f0ina. \u00der\u00e1tt fyrir a\u00f0 tilkynnt hafi veri\u00f0 um notkun lokunarb\u00fana\u00f0ar \u00e1 \u00f6\u00f0rum svi\u00f0um en hjarta- og \u00e6\u00f0askur\u00f0l\u00e6kningum, eru engar fregnir af \u00fev\u00ed a\u00f0 s\u00e1ralokunarb\u00fana\u00f0urinn hafi veri\u00f0 nota\u00f0ur til a\u00f0 loka skur\u00f0s\u00e1rum me\u00f0f\u00e6ddra sj\u00faklinga \u00fear sem mi\u00f0gildi sternotomy var ger\u00f0. \u00cd \u00feessari ranns\u00f3kn var meti\u00f0 hvort s\u00e1rlokunarb\u00fana\u00f0ur s\u00e9 gagnlegt og \u00f6ruggt t\u00e6ki til a\u00f0 loka\u00a0skur\u00f0a\u00f0ger\u00f0ir<\/a> hj\u00e1 me\u00f0f\u00e6ddum sj\u00faklingum eftir hjarta- og \u00e6\u00f0aa\u00f0ger\u00f0ir me\u00f0 mi\u00f0gildi sternot\u00f3ma.<\/span><\/p>

\u00a0<\/p>

Sam\u00feykkt til birtingar 23. mars 2016.<\/p>

Heimilisfang br\u00e9faskrifta til Dr Tanaka, Department of Pediatric Cardiac Surgery, Gunma Children's Medical Center, 779 Shimohakoda, Hokkitsumati, Shibukawa, Gunma 377-8577, Japan; netfang: tfjgp484@yahoo.co.jp.<\/span><\/p>

2016 af The Society of Thoracic Surgeons 0003-4975\/$36.00 Gefi\u00f0 \u00fat af Elsevier<\/span><\/p>

\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Sj\u00faklingar og a\u00f0fer\u00f0ir<\/p>

Ranns\u00f3knara\u00f0fer\u00f0in fyrir \u00feessa ranns\u00f3kn \u00e1 s\u00e1ralokunarb\u00fana\u00f0i var sam\u00feykkt af ranns\u00f3knarnefndinni hj\u00e1 stofnun okkar \u00ed samr\u00e6mi vi\u00f0 Helsinki-yfirl\u00fdsinguna.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Sj\u00faklingar og n\u00e1msh\u00f6nnun<\/p>

Ranns\u00f3knin \u00e1 s\u00e1ralokunarb\u00fana\u00f0i n\u00e1\u00f0i til 238 sj\u00faklinga sem f\u00f3ru \u00ed r\u00f6\u00f0 \u00ed hjartaa\u00f0ger\u00f0ir me\u00f0 mi\u00f0gildi sternot\u00f3m fr\u00e1 j\u00fan\u00ed 2014 til okt\u00f3ber 2015 \u00e1 hjarta- og \u00e6\u00f0askur\u00f0deild Gunma barnal\u00e6kningami\u00f0st\u00f6\u00f0varinnar \u00ed Shibukawa, Japan. Sj\u00faklingar sem skr\u00e1\u00f0ir voru inn var af handah\u00f3fi \u00fathluta\u00f0 \u00ed h\u00f3p me\u00f0 s\u00e1rlokunarb\u00fana\u00f0i (lokunarh\u00f3pur) e\u00f0a saumah\u00f3p undir h\u00fa\u00f0 (saumh\u00f3pur) me\u00f0 \u00fev\u00ed a\u00f0 nota t\u00f6lvueinfalda slembival og voru rannsaka\u00f0ir\u00a0tilvonandi (mynd 1). Allir sj\u00faklingar veittu skriflegt uppl\u00fdst sam\u00feykki fyrir \u00fe\u00e1ttt\u00f6ku.<\/span><\/p>

Sj\u00faklingar sem h\u00f6f\u00f0u gengist undir s\u00ed\u00f0b\u00fana lokun bringubeins og \u00feeir sem voru me\u00f0 annan litningagalla en \u00fer\u00edst\u00e6\u00f0u 21 voru \u00fatiloka\u00f0ir fr\u00e1 ranns\u00f3kninni til a\u00f0 einfalda mati\u00f0 \u00ed \u00feessari ranns\u00f3kn. Ranns\u00f3knin \u00fatiloka\u00f0i 20 sj\u00faklinga sem h\u00f6f\u00f0u seinka\u00f0a bringulokun, 1 sj\u00fakling sem var me\u00f0 annan litningagalla en \u00fer\u00edst\u00e6\u00f0u 21 og 3 sj\u00faklinga sem d\u00f3u innan 3 m\u00e1na\u00f0a fr\u00e1 a\u00f0ger\u00f0 og skildu eftir 214 sj\u00faklinga \u00ed \u00feessari ranns\u00f3kn. voru me\u00f0.<\/p>

L\u00fd\u00f0fr\u00e6\u00f0ilegum g\u00f6gnum og kl\u00edn\u00edskum einkennum var safna\u00f0 sem innih\u00e9ldu kyn, aldur, l\u00edkams\u00feyngd, hvort sj\u00faklingurinn v\u00e6ri me\u00f0 Downs-heilkenni e\u00f0a var ungbarn e\u00f0a n\u00fdburi, lengd skur\u00f0s\u00e1rs, heildara\u00f0ger\u00f0art\u00edmi og magn bl\u00e6\u00f0inga. Ni\u00f0urst\u00f6\u00f0urnar sem greindar voru \u00ed \u00feessari ranns\u00f3kn voru me\u00f0al annars snyrtiv\u00f6ru\u00fatlit, lokunart\u00edmi h\u00fa\u00f0ar og t\u00ed\u00f0ni fylgikvilla.<\/p>

Sj\u00faklingunum 214 var skipt \u00ed h\u00f3p me\u00f0 fyrstu a\u00f0ger\u00f0 (FO) e\u00f0a endura\u00f0ger\u00f0ah\u00f3p (RO) og hver h\u00f3pur var greindur me\u00f0 tilliti til fegur\u00f0ar\u00fatlits. Hins vegar voru allir sj\u00faklingar settir saman til a\u00f0 bera saman lokunart\u00edma h\u00fa\u00f0ar og t\u00ed\u00f0ni fylgikvilla \u00e1 milli lokunarh\u00f3psins og saumah\u00f3psins. Fyrirfram greindum vi\u00f0 hugsanlega fylgikvilla sem einkenndu s\u00e1rlokunarb\u00fana\u00f0inn, sem innih\u00e9ldu aflitun \u00e1 h\u00fa\u00f0, h\u00fa\u00f0\u00feekju, ofn\u00e6mi fyrir t\u00e6kinu og<\/p>

skemmdir \u00e1 og h\u00fa\u00f0fl\u00f6gnun t\u00e6kisins. \u00deessir fylgikvillar voru greindir \u00fat fr\u00e1 uppl\u00fdsingum fr\u00e1 fyrirt\u00e6kinu og pers\u00f3nulegri reynslu og skemmdir \u00e1 t\u00e6kinu voru einnig innifaldar til a\u00f0 meta \u00f6ryggi t\u00e6kisins.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Zhejiang\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

T\u00e6ki og t\u00e6kni<\/p>\n

\u00deeir 214 sj\u00faklingar sem t\u00f3ku \u00fe\u00e1tt \u00ed \u00feessari ranns\u00f3kn gengust undir hjarta- og \u00e6\u00f0aa\u00f0ger\u00f0ir me\u00f0 mi\u00f0gildi sternotom, me\u00f0 e\u00f0a \u00e1n hjarta- og lungahj\u00e1veitu. B\u00e6\u00f0i \u00ed lokunar- og saumah\u00f3pnum, vefjum undir h\u00fa\u00f0 voru sauma\u00f0ir me\u00f0 4-0 Vicryl (Ethicon, Cincinnati,OH) fr\u00e1soganlegum fj\u00f6l\u00fer\u00e1\u00f0asauma. \u00cd lokunarh\u00f3pnum var ysta yfirbor\u00f0i skur\u00f0s\u00e1rsins loka\u00f0 me\u00f0 s\u00e1ralokunarb\u00fana\u00f0inum (mynd 2). \u00cd saumah\u00f3pnum voru samfelldar saumar undir h\u00fa\u00f0 venjulega settar me\u00f0 \u00fev\u00ed a\u00f0 nota 5-0 Prolene sauma (Ethicon) me\u00f0 skur\u00f0a\u00f0ger\u00f0arklemmunni \u00e1 enda saumsins.<\/span><\/p>\n

S\u00e1rv\u00f6rn n\u00e1\u00f0ist me\u00f0 \u00fev\u00ed a\u00f0 nota dau\u00f0hreinsa\u00f0a grisju, sem skipt var \u00fat fyrir n\u00fdja grisju, \u00e1n s\u00f3tthreinsiefnis, ef h\u00fan var blettu\u00f0 af svita e\u00f0a \u00fatfl\u00e6\u00f0i. Hj\u00e1 \u00f6llum sj\u00faklingum var t\u00e6ki\u00f0 fjarl\u00e6gt e\u00f0a sauma fjarl\u00e6g\u00f0 7 d\u00f6gum eftir a\u00f0ger\u00f0. S\u00e1rlokunarb\u00fana\u00f0urinn var fjarl\u00e6g\u00f0ur me\u00f0 \u00fev\u00ed a\u00f0 nota vi\u00f0lo\u00f0un (Nichiban, Bunkyo, Tokyo, Japan) til a\u00f0 vernda h\u00fa\u00f0ina. Eftir a\u00f0 t\u00e6ki\u00f0 e\u00f0a saumana voru fjarl\u00e6g\u00f0 fengu sj\u00faklingar a\u00f0 fara \u00ed ba\u00f0.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Longmed\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Eftirfylgni og gagna\u00f6flun<\/p>

Rafr\u00e6n sj\u00fakraskr\u00e1 og japanski gagnagrunnur um me\u00f0f\u00e6dda hjarta- og \u00e6\u00f0askur\u00f0a\u00f0ger\u00f0ir voru nota\u00f0ar sem t\u00e6ki til a\u00f0 skr\u00e1 kl\u00edn\u00edsk g\u00f6gn. \u00d6ll l\u00fd\u00f0fr\u00e6\u00f0ileg g\u00f6gn og kl\u00edn\u00edsk einkenni voru skr\u00e1\u00f0 fyrir a\u00f0ger\u00f0 og\u00a0\u00ed a\u00f0ger\u00f0. H\u00fa\u00f0lokunart\u00edmar voru skr\u00e1\u00f0ir \u00ed a\u00f0ger\u00f0 me\u00f0 skei\u00f0klukku. S\u00e1rame\u00f0fer\u00f0in\u00a0<\/span>si\u00f0areglum var beitt fyrir alla sj\u00faklinga. Eftirfylgni og fylgikvillum var safna\u00f0 af 3 hjarta- og \u00e6\u00f0askur\u00f0l\u00e6knum 1, 2, 4, 8 og 12 vikum eftir a\u00f0ger\u00f0. Snyrtilegt \u00fatlit var skr\u00e1\u00f0 3 m\u00e1nu\u00f0um eftir a\u00f0ger\u00f0. Eftir \u00fatskrift var sj\u00faklingum fylgt eftir sem g\u00f6ngudeildarsj\u00faklingar \u00e1 stofnuninni okkar.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

S\u00e1rsmat<\/p>

Mat \u00e1 fegrunar\u00e1rangri var framkv\u00e6mt af 2 l\u00fdtal\u00e6knum 3 m\u00e1nu\u00f0um eftir a\u00f0ger\u00f0ina sem voru blinda\u00f0ir fyrir \u00fev\u00ed hvers konar h\u00fa\u00f0lokun var notu\u00f0. Snyrtiv\u00f6ru\u00fatliti\u00f0 var meti\u00f0 me\u00f0 Vancouver Scar Scale (VSS), vi\u00f0urkenndum bruna\u00f6rakvar\u00f0a sem Sullivan l\u00fdsti fyrst \u00e1ri\u00f0 1990. VSS er s\u00e1 m\u00e6likvar\u00f0i sem oftast er nota\u00f0ur fyrir skur\u00f0a\u00f0ger\u00f0ar\u00f6r [9\u201311] og hefur fj\u00f6gur flokkar bygg\u00f0ir \u00e1 \u00e6\u00f0avirkni, litarefni, sveigjanleika og h\u00e6\u00f0 [12]. Heildarstigi\u00f0 er \u00e1 bilinu 0 til 13, \u00fear sem einkunnin 0 endurspeglar e\u00f0lilega h\u00fa\u00f0 (tafla 1).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Tafla\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

T\u00f6lfr\u00e6\u00f0ilegar a\u00f0fer\u00f0ir<\/p>

StatView 5.0 hugb\u00fana\u00f0ur (SAS Institute Inc, Cary, NC) og Excel 2013 (Microsoft Corp, Redmond, WA) voru nota\u00f0ir fyrir\u00a0Gagnagreining. Ni\u00f0urst\u00f6\u00f0ur eru settar fram sem me\u00f0al SD e\u00f0a mi\u00f0gildi og millifj\u00f3r\u00f0ungsbil me\u00f0 95% \u00f6ryggi \u00ed bilum fyrir megindlegar breytur, og flokka\u00f0ar breytur eru teknar saman me\u00f0 algerri t\u00ed\u00f0ni og pr\u00f3sentum aldri. Samfelldar breytur voru bornar saman me\u00f0 nemendapr\u00f3fi og Mann-Whitney U pr\u00f3fi. Flokksbreytur voru bornar saman me\u00f0 \u00fev\u00ed a\u00f0 nota Pearson X\u00b2 pr\u00f3fi\u00f0 e\u00f0a vi\u00f0 Fisher n\u00e1kv\u00e6ma pr\u00f3fi\u00f0 \u00feegar v\u00e6ntanleg t\u00ed\u00f0ni var minni en 5. P gildi upp \u00e1 0,05 e\u00f0a minna voru talin t\u00f6lfr\u00e6\u00f0ilega markt\u00e6k.<\/span><\/p>

\u00a0<\/p>

Ni\u00f0urst\u00f6\u00f0ur<\/span><\/p>

\u00cd FO h\u00f3pnum voru 136 sj\u00faklingar (lokunarh\u00f3pur: 71 sj\u00faklingur; saumah\u00f3pur: 65 sj\u00faklingar) og RO h\u00f3pur haf\u00f0i 78 sj\u00faklinga (lokunarh\u00f3pur: 42 sj\u00faklingar; saumah\u00f3pur: 36 sj\u00faklingar). G\u00f6ngudeildin okkar fylgdist me\u00f0 \u00f6llum sj\u00faklingum \u00ed meira en 3 m\u00e1nu\u00f0i eftir hjartaa\u00f0ger\u00f0. Greining \u00e1 l\u00fd\u00f0fr\u00e6\u00f0ilegum g\u00f6gnum og kl\u00edn\u00edskum einkennum s\u00fdndi a\u00f0 \u00fea\u00f0 voru engin\u00a0markt\u00e6kur munur \u00e1 h\u00f3pnum og saumah\u00f3pnum (tafla 2). \u00dea\u00f0 var heldur enginn markt\u00e6kur munur\u00a0<\/span>\u00ed heildarme\u00f0altal VSS skora \u00ed RO h\u00f3pnum fyrir a\u00f0ger\u00f0 (lokun: VSS 3,2 1,2; saumur: VSS 3,3 1,3; p \u00bc 0,57). Me\u00f0alaldur og l\u00edkams\u00feyngd voru h\u00e6rri \u00ed RO h\u00f3pnum samanbori\u00f0 vi\u00f0 FO h\u00f3pinn og me\u00f0alheildara\u00f0ger\u00f0art\u00edmi var lengri \u00ed RO h\u00f3pnum, \u00fe\u00f3 \u00feessar ni\u00f0urst\u00f6\u00f0ur v\u00e6ru ekki markt\u00e6kar.<\/span><\/p>

\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Snyrtiv\u00f6rur \u00fatlit<\/p>

Snyrtilegt \u00fatlit var meti\u00f0 af VSS 3 m\u00e1nu\u00f0um eftir a\u00f0ger\u00f0 (mynd 3). \u00cd FO h\u00f3pnum var VSS \u00ed lokunarh\u00f3pnum markt\u00e6kt l\u00e6gra en saumah\u00f3pinn fyrir allar VSS breytur (tafla 3). \u00cd RO h\u00f3pnum voru \u00e6\u00f0avirkni, litarefni og heildar VSS skor markt\u00e6kt l\u00e6gri \u00ed lokunarh\u00f3pnum en \u00ed saumah\u00f3pnum. A\u00f0 auki var heildar VSS skor hj\u00e1 sj\u00faklingum me\u00f0 \u00fer\u00edst\u00e6\u00f0u 21 markt\u00e6kt l\u00e6gra \u00ed lokunarh\u00f3pnum samanbori\u00f0 vi\u00f0 saumah\u00f3pinn (tafla4). Ennfremur var heildar VSS skor hj\u00e1 ungb\u00f6rnum markt\u00e6kt l\u00e6gra \u00ed lokunarh\u00f3pnum en \u00ed saumah\u00f3pnum (tafla). 5). \u00c1 sama h\u00e1tt, hj\u00e1 n\u00fdburum, var heildar VSS skor lokunarh\u00f3psins markt\u00e6kt l\u00e6gra en saumah\u00f3psins (3,0 2,0 \u00e1 m\u00f3ti 5,2 2,3, p < 0,017). Enginn markt\u00e6kur munur var \u00e1 VSS stigum fyrir lokun s\u00e1ra (p \u00bc 0,96) og sauma (p \u00bc 0,79) \u00e1 milli skur\u00f0l\u00e6knanna tveggja.<\/p>

\u00a0<\/p>

S\u00e1rlokunarb\u00fana\u00f0ur H\u00fa\u00f0lokunart\u00edmi<\/p>

Munurinn \u00e1 heildara\u00f0ger\u00f0art\u00edma milli lokunarh\u00f3psins og saumah\u00f3psins (340,3 127,1 m\u00edn\u00fatur \u00e1 m\u00f3ti 328,2 120,7 m\u00edn\u00fatur) var ekki markt\u00e6kur (p \u00bc 0,70). Hins vegar var lokunart\u00edmi h\u00fa\u00f0arinnar \u00ed lokunarh\u00f3pnum markt\u00e6kt styttri en \u00ed saumah\u00f3pur (113,0 9,1 sek\u00fandur \u00e1 m\u00f3ti 375,9 60,2 sek\u00fandur, p <0,001; mynd 4). Mi\u00f0gildi lokunart\u00edma h\u00fa\u00f0ar var 113 sek\u00fandur (\u00e1 bilinu 98 til 135 sek\u00fandur) \u00ed lokunarh\u00f3pnum og 389 sek\u00fandur (\u00e1 bilinu 256 til 470 sek\u00fandur) \u00ed saumah\u00f3pnum.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Tafla\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Fylgikvillar og l\u00edkamlegar ni\u00f0urst\u00f6\u00f0ur<\/p>

Hlutfall fylgikvilla var bori\u00f0 saman \u00e1 milli lokunarh\u00f3ps (n \u00bc 113) og saumah\u00f3ps (n \u00bc 101). S\u00fdking \u00ed skur\u00f0a\u00f0ger\u00f0 kom fram hj\u00e1 1 sj\u00faklingi \u00ed lokunarh\u00f3pnum og hj\u00e1 2 sj\u00faklingum \u00ed saumah\u00f3pnum. Hlutfall skur\u00f0a\u00f0ger\u00f0ars\u00fdkingar var ekki markt\u00e6kt \u00f3l\u00edkt \u00e1 milli lokunarh\u00f3psins og saumah\u00f3psins (0,9% \u00e1 m\u00f3ti 2,0%, p \u00bc 0,50). Skur\u00f0s\u00e1rsbrot kom fram hj\u00e1 2 sj\u00faklingum \u00ed lokunarh\u00f3pnum og hj\u00e1 3 sj\u00faklingum \u00ed saumah\u00f3pnum. Enginn markt\u00e6kur munur var \u00e1 losun skur\u00f0s\u00e1ra milli h\u00f3panna tveggja (1,8% \u00e1 m\u00f3ti 3,0%, p \u00bc 0,56). Allir sj\u00faklingar sem losna\u00f0i s\u00e1r hj\u00e1 voru n\u00fdburar e\u00f0a me\u00f0 \u00fer\u00edst\u00e6\u00f0u 21. Fylgikvillar sem komu fram sem eru s\u00e9rkennilegir fyrir lokunarb\u00fana\u00f0 voru me\u00f0al annars aflitun \u00e1 h\u00fa\u00f0 (0,9%), h\u00fa\u00f0\u00feekju (0,9%) og h\u00fa\u00f0fl\u00f6gnun t\u00e6kisins (1,8%). Litabreyting var\u00f0 vegna goss \u00e1 l\u00edmbandinu, sem var b\u00e6tt me\u00f0 \u00fev\u00ed a\u00f0 bera \u00e1 sterasmyrsl. Epidermolysis var einnig me\u00f0h\u00f6ndla\u00f0 me\u00f0 smyrslinu. N\u00fd t\u00e6ki voru sett \u00e1 sj\u00faklinga \u00fear sem t\u00e6kin flagnu\u00f0u af.<\/p>

Engir alvarlegir fylgikvillar komu \u00fe\u00f3 fram, svo sem ofn\u00e6mi fyrir e\u00f0a skemmdum \u00e1 t\u00e6kjunum. Vi\u00f0 g\u00e1tum ekki meti\u00f0 kl\u00e1\u00f0a e\u00f0a s\u00e1rsauka vegna \u00feess a\u00f0 barnasj\u00faklingar okkar, \u00fear \u00e1 me\u00f0al ungb\u00f6rn, g\u00e1tu ekki kvarta\u00f0 yfir \u00feessum einkennum.<\/p>

Hins vegar, me\u00f0an s\u00e1rlokunarb\u00fana\u00f0ur e\u00f0a sauma var fjarl\u00e6g\u00f0ur, gr\u00e9tu markt\u00e6kt f\u00e6rri sj\u00faklingar e\u00f0a kv\u00f6rtu\u00f0u \u00ed lokunarh\u00f3pnum samanbori\u00f0 vi\u00f0 saumah\u00f3pinn (7.1% \u00e1 m\u00f3ti 52.5%, p < 0.001).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Longmed\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Tafla\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Tafla\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Tafla\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Lokunart\u00edmi\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Athugasemd
\u00deessi ranns\u00f3kn er fyrsta slembira\u00f0a\u00f0a samanbur\u00f0arranns\u00f3knin \u00e1 s\u00e1ralokunarb\u00fana\u00f0i hj\u00e1 b\u00f6rnum sem gengust undir hjartaa\u00f0ger\u00f0ir. \u00der\u00e1tt fyrir a\u00f0 nokkrar n\u00fdlegar tilvikssk\u00fdrslur tengdar s\u00e1ralokunarb\u00fana\u00f0inum hafi veri\u00f0 kynntar, greindi engin fr\u00e1 hjartaa\u00f0ger\u00f0um me\u00f0 mi\u00f0gildi sternotomy [7, 8]. Einnig er \u00e1vinningur e\u00f0a fylgikvillah\u00e6tta hj\u00e1 b\u00f6rnum enn \u00f3\u00feekktur. \u00cd ranns\u00f3kn okkar metum vi\u00f0 barnasj\u00faklinga sem h\u00f6f\u00f0u gengist undir hjartaa\u00f0ger\u00f0ir me\u00f0 mi\u00f0gildi sternotom. Ni\u00f0urst\u00f6\u00f0ur okkar s\u00fdndu markt\u00e6kt betri \u00fatkomu \u00ed lokunarh\u00f3pnum samanbori\u00f0 vi\u00f0 saumah\u00f3pinn. \u00cd lj\u00f3si \u00feess a\u00f0 fj\u00f6ldi \u00fe\u00e1tta hefur \u00e1hrif \u00e1 snyrtilegt \u00fatlit skur\u00f0s\u00e1ra, svo sem notkun rafskauta, s\u00fdkingar, n\u00e1lgunar og saumaefnis [13-15] , vi\u00f0 notu\u00f0um samr\u00e6mda skur\u00f0a\u00f0ger\u00f0 og saumaefni og rafskaut var nota\u00f0 til a\u00f0 framkv\u00e6ma mi\u00f0gildi sternotomy hj\u00e1 \u00f6llum sj\u00faklingum. Ni\u00f0urst\u00f6\u00f0ur okkar s\u00fdndu fram \u00e1 a\u00f0 s\u00e1ralokunarb\u00fana\u00f0urinn hefur snyrtifr\u00e6\u00f0ilegan \u00e1vinning, hvort sem um var a\u00f0 r\u00e6\u00f0a fyrstu a\u00f0ger\u00f0 e\u00f0a endura\u00f0ger\u00f0. \u00cd hjartaskur\u00f0a\u00f0ger\u00f0um barna eru margir sj\u00faklingar me\u00f0 \u00fer\u00edst\u00e6\u00f0u 21 [16]. Ennfremur, fyrir b\u00f6rn sem eru me\u00f0 hjartagalla, eru hjartaa\u00f0ger\u00f0ir oft ger\u00f0ar \u00e1 frumbernsku [17, 18].<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u00c1 grundvelli ni\u00f0ursta\u00f0na \u00feessarar tilraunar teljum vi\u00f0 a\u00f0 h\u00e6gt s\u00e9 a\u00f0 nota \u00feetta s\u00e1rlokunart\u00e6ki me\u00f0 g\u00f3\u00f0um \u00e1rangri \u00e1 fj\u00f6lm\u00f6rgum sj\u00faklingum.
A\u00f0 \u00fev\u00ed er var\u00f0ar lokunart\u00edma h\u00f6f\u00f0u skur\u00f0s\u00e1r sem voru loku\u00f0 me\u00f0 s\u00e1ralokunarb\u00fana\u00f0i auglj\u00f3slega fr\u00e1b\u00e6ra frammist\u00f6\u00f0u samanbori\u00f0 vi\u00f0 lokun s\u00e1ra me\u00f0 sauma. \u00c1 sama h\u00e1tt getur notkun 2-okt\u00fdls\u00fdan\u00f3kr\u00fdlatl\u00edms einnig dregi\u00f0 \u00far lokunart\u00edma skur\u00f0a\u00f0ger\u00f0ars\u00e1ra [4, 19]. Hins vegar eru engar sk\u00fdrslur \u00fear sem okt\u00fdls\u00fdan\u00f3akr\u00fdlat hefur veri\u00f0 nota\u00f0 vi\u00f0 mi\u00f0gildi sternot\u00f3munar, sem gerir samanbur\u00f0 \u00e1 \u00f6ryggi \u00feess og lokunart\u00edma vi\u00f0 s\u00e1ralokunarb\u00fana\u00f0inn erfi\u00f0an. \u00cd \u00feessari ranns\u00f3kn er
t\u00edmabundin dreifing \u00e1 lokunart\u00edma h\u00fa\u00f0ar \u00ed lokunarh\u00f3pnum var afar l\u00edtil, sem \u00fe\u00fd\u00f0ir a\u00f0 notkun \u00feessa t\u00e6kis haf\u00f0i ekki \u00e1hrif \u00e1 lengd s\u00e1rsins e\u00f0a mismunandi skur\u00f0l\u00e6kna. \u00dev\u00ed lengur sem s\u00e1ri\u00f0 er, \u00fev\u00ed meiri hlutfallslegan \u00e1vinning m\u00e1 b\u00faast vi\u00f0.
\u00der\u00e1tt fyrir a\u00f0 munur \u00e1 t\u00ed\u00f0ni s\u00fdkingar \u00ed skur\u00f0s\u00e1rum \u00e1 milli lokunarh\u00f3psins og saumah\u00f3psins hafi ekki veri\u00f0 markt\u00e6kur, komu f\u00e6rri s\u00e1ras\u00fdkingar fram \u00ed lokunarh\u00f3pnum. Tilkynnt hefur veri\u00f0 um a\u00f0 t\u00ed\u00f0ni s\u00fdkingar \u00e1 skur\u00f0sta\u00f0 eftir hjartaa\u00f0ger\u00f0ir barna s\u00e9 \u00e1 bilinu 2,3% til 8% [20-23]. \u00cd \u00feessari ranns\u00f3kn var t\u00ed\u00f0ni s\u00e1ras\u00fdkingar eftir skur\u00f0a\u00f0ger\u00f0 \u00ed lokunarh\u00f3pnum 0,9%, sem er afar l\u00e1gt s\u00fdkingart\u00ed\u00f0ni mi\u00f0a\u00f0 vi\u00f0 a\u00f0 engar leifar voru \u00ed h\u00fa\u00f0\u00feekju \u00ed lokunarh\u00f3pnum. Notkun k\u00edsilhlaups til a\u00f0 koma \u00ed veg fyrir skur\u00f0s\u00e1ras\u00fdkingar e\u00f0a hyper trophic \u00f6r hafa veri\u00f0 kynnt [24\u201326]. Hins vegar hefur s\u00e1ralokunarb\u00fana\u00f0urinn \u00feann aukna \u00e1vinning a\u00f0 stytta s\u00e1rslokunart\u00edmann
auk \u00feess a\u00f0 koma \u00ed veg fyrir s\u00fdkingar \u00ed skur\u00f0s\u00e1rum og skur\u00f0ar\u00f6r.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Svipa\u00f0 og t\u00ed\u00f0ni s\u00e1ras\u00fdkinga var t\u00ed\u00f0ni skur\u00f0s\u00e1ra sem losna\u00f0i \u00ed Z h\u00f3pnum j\u00f6fn e\u00f0a h\u00e6rri en \u00ed saumah\u00f3pnum. Hins vegar hefur s\u00e1rlokunarb\u00fana\u00f0urinn meiri sveigjanleika til a\u00f0 losna vi\u00f0 s\u00e1r og er ekki \u00edfarandi. Vi\u00f0 fjarl\u00e6g\u00f0um sauminn e\u00f0a t\u00e6ki\u00f0 7 d\u00f6gum eftir a\u00f0ger\u00f0ina \u00ed samr\u00e6mi vi\u00f0 h\u00f6nnun ranns\u00f3knar. Hins vegar teljum vi\u00f0 a\u00f0 fjarl\u00e6ging t\u00e6kisins \u00e6tti a\u00f0 fara fram eftir \u00e1standi s\u00e1rs hj\u00e1 n\u00fdburum og sj\u00faklingum me\u00f0 \u00fer\u00edst\u00e6\u00f0u 21 vegna \u00feess a\u00f0 s\u00e1rbrot s\u00e1st eing\u00f6ngu hj\u00e1 \u00feessum sj\u00faklingum. Fylgikvillar sem einkennast af t\u00e6kinu eru aflitun \u00e1 h\u00fa\u00f0, h\u00fa\u00f0\u00feekju og h\u00fa\u00f0fl\u00f6gnun t\u00e6kisins, \u00fe\u00f3 a\u00f0 enginn hafi komi\u00f0 fram \u00ed miklum hra\u00f0a e\u00f0a veri\u00f0 alvarlegur. \u00dear af lei\u00f0andi komumst vi\u00f0 a\u00f0 \u00feeirri ni\u00f0urst\u00f6\u00f0u a\u00f0 h\u00e6gt v\u00e6ri a\u00f0 nota s\u00e1ralokunarb\u00fana\u00f0inn \u00e1 \u00f6ruggan h\u00e1tt.
Yfirbur\u00f0a eiginleiki s\u00e1rlokunarb\u00fana\u00f0arins er h\u00e6fileikinn til a\u00f0 stilla lengd \u00feess og spennu. Lengd t\u00e6kisins er au\u00f0velt a\u00f0 stilla me\u00f0 \u00fev\u00ed a\u00f0 klippa t\u00e6ki\u00f0 \u00e1 vi\u00f0eigandi sta\u00f0. H\u00e6gt er a\u00f0 stilla spennuna \u00e1 t\u00e6kinu \u00e1n takmarkana vegna a\u00f0l\u00f6gunar belt-rock kerfisins. Til d\u00e6mis er h\u00e6gt a\u00f0 stilla spennuna \u00e1 t\u00e6kinu margsinnis \u00ed samr\u00e6mi vi\u00f0 umfang bj\u00fags e\u00f0a s\u00e1ragr\u00e6\u00f0slu eftir a\u00f0ger\u00f0. Ennfremur er h\u00e6gt a\u00f0 sta\u00f0festa hversu gr\u00f3andi s\u00e1r eru me\u00f0 \u00fev\u00ed a\u00f0 aftengja rennil\u00e1sana. \u00deannig getur t\u00e6ki\u00f0 teki\u00f0 vi\u00f0 losun me\u00f0 \u00fev\u00ed a\u00f0 rugga rennil\u00e1snum aftur, \u00e1n \u00feess a\u00f0 sauma \u00feurfi.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Af ni\u00f0urst\u00f6\u00f0um \u00far \u00feessari ranns\u00f3kn teljum vi\u00f0 a\u00f0 st\u00e6rstu kostir \u00feess a\u00f0 nota s\u00e1ralokunarb\u00fana\u00f0inn s\u00e9u gott snyrtilegt \u00fatlit og styttur lokunart\u00edmi. Einnig var \u00f6ryggi t\u00e6kisins jafn gott og undirh\u00fa\u00f0 saumar. Hins vegar var s\u00e9rkenni s\u00e1ralokunarb\u00fana\u00f0arins a\u00f0 \u00fea\u00f0 var minna s\u00e1rsaukafullt \u00feegar \u00fea\u00f0 var fjarl\u00e6gt, sem gerir \u00fea\u00f0 s\u00e9rstaklega gagnlegt fyrir b\u00f6rn. Reyndar h\u00f6f\u00f0u markt\u00e6kt f\u00e6rri sj\u00faklingar \u00ed lokunarh\u00f3pnum s\u00e1rsauka e\u00f0a gr\u00e9tu \u00feegar t\u00e6ki\u00f0 var fjarl\u00e6gt e\u00f0a sauma samanbori\u00f0 vi\u00f0 saumah\u00f3pinn. Aftur \u00e1 m\u00f3ti er kostna\u00f0ur vi\u00f0 s\u00e1rlokunarb\u00fana\u00f0inn ekki eins g\u00f3\u00f0ur og sauma. Kostna\u00f0ur vi\u00f0 s\u00e1rlokunarb\u00fana\u00f0 er $85, sem er um \u00fea\u00f0 bil \u00ferisvar sinnum h\u00e6rri en kostna\u00f0ur vi\u00f0 sauma undir h\u00fa\u00f0. Hins vegar teljum vi\u00f0 a\u00f0 \u00feetta t\u00e6ki s\u00e9 vel \u00feess vir\u00f0i a\u00f0 nota mi\u00f0a\u00f0 vi\u00f0 snyrtiv\u00f6rur og virkni \u00feess \u00ed lokunart\u00edma.<\/p>

\u00deessi ranns\u00f3kn hefur nokkrar takmarkanir. \u00cd fyrsta lagi var \u00feessi ranns\u00f3kn ger\u00f0 \u00e1 einni stofnun; \u00fev\u00ed er alh\u00e6fing \u00e1 ni\u00f0urst\u00f6\u00f0um okkar takm\u00f6rku\u00f0. Hins vegar eru \u00feessar uppl\u00fdsingar mikilv\u00e6gar vegna \u00feess a\u00f0 \u00feetta er fyrsta tilvonandi slembira\u00f0a\u00f0a ranns\u00f3knin sem greinir fr\u00e1 notkun s\u00e1rslokunarb\u00fana\u00f0arins hj\u00e1 b\u00f6rnum sem gengust undir brj\u00f3stholsskur\u00f0.<\/p>

\u00cd \u00f6\u00f0ru lagi er fj\u00f6ldi sj\u00faklinga me\u00f0 Downs-heilkenni tilt\u00f6lulega l\u00edtill, sem lei\u00f0ir til \u00f3fulln\u00e6gjandi t\u00f6lfr\u00e6\u00f0ilegra krafta til a\u00f0 meta skilvirkni t\u00e6kisins hj\u00e1 Downs-heilkennis\u00fe\u00fd\u00f0inu.<\/p>

\u00cd \u00feri\u00f0ja lagi \u00fatiloku\u00f0u ranns\u00f3knin sj\u00faklinga me\u00f0 litningagalla, nema \u00fer\u00edst\u00e6\u00f0u 21, og sj\u00faklinga sem h\u00f6f\u00f0u seinka\u00f0a lokun bringubeins. \u00deannig g\u00e1tum vi\u00f0 ekki sko\u00f0a\u00f0 ni\u00f0urst\u00f6\u00f0ur \u00ed \u00feessum h\u00f3pum. Var\u00f0andi t\u00e6ki og t\u00e6kni, samfelld undirh\u00fa\u00f0saum me\u00f0 \u00f3gleypanlegum p\u00f3l\u00fdpr\u00f3p\u00fdlensaumum me\u00f0 fjarl\u00e6gingu \u00e1 saumum getur veri\u00f0 sjaldg\u00e6f a\u00f0fer\u00f0. A\u00f0 lokum var \u00feessi ranns\u00f3kn slembir\u00f6\u00f0u\u00f0 ranns\u00f3kn \u00e1 b\u00f6rnum og vi\u00f0 sko\u00f0u\u00f0um ekki skilvirkni hj\u00e1 fullor\u00f0num sj\u00faklingum. \u00deess vegna er v\u00e6ntanleg, slembir\u00f6\u00f0u\u00f0 kl\u00edn\u00edsk ranns\u00f3kn \u00e1 fullor\u00f0num sj\u00faklingum nau\u00f0synleg til a\u00f0 sannreyna notkun t\u00e6kisins hj\u00e1 fullor\u00f0num.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

A\u00f0 lokum er \u00feetta fyrsta slembira\u00f0a\u00f0a ranns\u00f3knin sem metur ni\u00f0urst\u00f6\u00f0ur rennil\u00e1ssins Longmed s\u00e1ralokunarb\u00fana\u00f0ar hj\u00e1 b\u00f6rnum sem gengust undir hjartaa\u00f0ger\u00f0ir me\u00f0 mi\u00f0gildi sternotomy. Ranns\u00f3kn okkar s\u00fdndi a\u00f0 t\u00e6ki\u00f0 hefur fram\u00farskarandi \u00e1rangur \u00ed a\u00f0 b\u00e6ta snyrtiv\u00f6ru\u00fatliti\u00f0 og draga \u00far lokunart\u00edma h\u00fa\u00f0arinnar. \u00deetta er ekki \u00edfarandi t\u00e6ki sem h\u00e6gt er a\u00f0 nota \u00e1 einfaldan og \u00f6ruggan h\u00e1tt og g\u00e6ti henta\u00f0 b\u00f6rnum vegna \u00feess a\u00f0 \u00fea\u00f0 er minna s\u00e1rsaukafullt.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Heimildir<\/p>

  1. Jina H, Simcock J. Mi\u00f0gildi sternotomy \u00f6r mat. NZ Med J 2011;124:57\u201362.<\/li>
  2. Cotogni P, Barbero C, Rinaldi M. Dj\u00fap brj\u00f3sts\u00e1rss\u00fdking eftir hjartaa\u00f0ger\u00f0: s\u00f6nnunarg\u00f6gn og deilur. World J Care Med 2015;4:265\u201373.<\/li>
  3. Lemaignen A, Birgind G, Ghodhbane W, et al. Brj\u00f3sts\u00e1rss\u00fdking eftir hjartaa\u00f0ger\u00f0: t\u00ed\u00f0ni og \u00e1h\u00e6ttu\u00fe\u00e6ttir samkv\u00e6mt kl\u00edn\u00edskri framsetningu. Clin Microbiol Infect 2015;21:674.e11\u201318.<\/li>
  4. Krishnamoorthy B, Najam O, Kharn UA, Waterworth P, Fildes JE, Yonan N. Slembira\u00f0a\u00f0 tilvonandi ranns\u00f3kn sem ber saman hef\u00f0bundna h\u00fa\u00f0lokun undir h\u00fa\u00f0 me\u00f0 Dermabond h\u00fa\u00f0l\u00edmi eftir uppskeru saphenous vein. Ann Thorac Surg 2009;88:1445\u201350.<\/li><\/ol>
    1. Chambers A, Scarci M. Er h\u00fa\u00f0lokun me\u00f0 s\u00fdan\u00f3kr\u00fdlatl\u00edmi \u00e1rangursr\u00edk til a\u00f0 koma \u00ed veg fyrir s\u00fdkingar \u00ed bringubeini.Interact CardioVasc Thorac Surg 2010;10:793\u20136.<\/li>
    2. Lavazzo C, Gkegkes ID, Vouloumanou EK, Mamais I, Peppas G, Falagas ME. Saumar \u00e1 m\u00f3ti heftum til a\u00f0 me\u00f0h\u00f6ndla skur\u00f0s\u00e1r: safngreining \u00e1 slembir\u00f6\u00f0u\u00f0um samanbur\u00f0arranns\u00f3knum. Am Surg2011;77:1206\u201321.<\/li>
    3. Gorsulowsky DC, Talmor G. N\u00fdtt s\u00e1ralokunart\u00e6ki sem ekki er \u00edfarandi sem s\u00ed\u00f0asta lagi\u00f0 \u00ed h\u00fa\u00f0lokun. Dermatol Surg 2015;41:987\u20139.<\/li>
    4. Mar\u00eda ED. N\u00fdtt h\u00fa\u00f0lokakerfi au\u00f0veldar s\u00e1rsgr\u00e6\u00f0slu eftir hjarta- og \u00e6\u00f0a\u00edgr\u00e6\u00f0slu rafeindat\u00e6kjaa\u00f0ger\u00f0a. Heimur J Clin Cases 2015;3:675\u20137.<\/li>
    5. Bae SH, Bae YC. Greining \u00e1 notkunart\u00ed\u00f0ni mismunandi \u00f6rmatskvar\u00f0a \u00fat fr\u00e1 hr\u00e6\u00f0slu\u00e1standi og me\u00f0fer\u00f0ara\u00f0fer\u00f0. Arch Plast Surg 2014;41:111\u20135.<\/li>
    6. Truong PT, Abnousi F, Yong CM, o.fl. Sta\u00f0la\u00f0 mat \u00e1 skur\u00f0a\u00f0ger\u00f0ar\u00f6rum me\u00f0 brj\u00f3stakrabbameini sem sam\u00fe\u00e6ttir Vancouver \u00f6rskala, skammt\u00edma McGill verkjaspurningalista og sj\u00f3narhorn sj\u00faklinga. Plast Reconstr Surg 2005;116:1291\u20139.<\/li><\/ol>
      1. Lee SH, Zheng Z, Roh MR. Snemma me\u00f0h\u00f6ndlun \u00e1 skur\u00f0a\u00f0ger\u00f0ar\u00f6rum eftir a\u00f0ger\u00f0 me\u00f0 \u00fev\u00ed a\u00f0 nota hlutad\u00edox\u00ed\u00f0 leysir: klofin \u00f6r, matsblind ranns\u00f3kn. Dermatol Surg 2013;39:1190\u20136.<\/li>
      2. Femonti R, Bond J, Erdmann D, Levinson H. Yfirlit um \u00f6r og \u00f6r m\u00e6lit\u00e6ki. Eplasty 2010;10:e43.<\/li>
      3. S\u00f6ngvarinn AJ, Quinn JV, Thode HC Jr, Hollander JE. Aflei\u00f0ingar l\u00e9legrar \u00fatkomu eftir rifur og skur\u00f0a\u00f0ger\u00f0. Plast Reconstr Surg 2002;110:429\u201337.<\/li>
      4. Niessen FB, Spauwen PH, Kon M. Hlutverk saumaefnis \u00ed ofst\u00e6kkun \u00f6r: monocryl vs vicryl-rapide. Ann Plast Surg 1997;39:254\u201360.<\/li>
      5. Crossland DS, Jackson SP, Lyall R, o.fl. Vi\u00f0horf sj\u00faklinga til sternot\u00f3munar og brj\u00f3stholsskur\u00f0ar. Thorac Cardiovasc Surg 2005;53:93\u20135.<\/li>
      6. Freeman SB, Taft LE, Dooley KJ, o.fl. \u00cdb\u00faaranns\u00f3kn \u00e1 me\u00f0f\u00e6ddum hjartag\u00f6llum \u00ed Downs heilkenni. Am J Med Genet 1998;80:213\u20137.<\/li>
      7. Moller J. Algengi og t\u00ed\u00f0ni hjartagalla. \u00cd: M\u00f6ller JH (ritstj.). Perspectives in pediatric cardiology: surgery of congenital heart disease: Pediatric Cardiac Care Consortium, 1984-1995. Armonk, NY: Futura; 1998: 619\u201326.<\/li>
      8. Dickinson DF, Arnold R, Wilkinson JL. Me\u00f0f\u00e6ddur hjartasj\u00fakd\u00f3mur me\u00f0al 160 480 lifandi f\u00e6ddra barna \u00ed Liverpool 1960 til 1969. Aflei\u00f0ingar fyrir skur\u00f0a\u00f0ger\u00f0. Br Heart J 1981;46:55\u201362.<\/li><\/ol>
        1. Quinn J, Wells G, Sutcliffe T, o.fl. Slembir\u00f6\u00f0u\u00f0 ranns\u00f3kn sem ber saman okt\u00fdls\u00fdan\u00f3akr\u00fdlat vefjal\u00edm og sauma vi\u00f0 me\u00f0h\u00f6ndlun \u00e1 s\u00e1rum. JAMA 1997;277:1527\u201330.<\/li>
        2. Barker GM, O'Brien SM, Welke KF, o.fl. Mikil s\u00fdking eftir hjartaa\u00f0ger\u00f0 barna: \u00e1h\u00e6ttumatsl\u00edkan. Ann Thorac Surg 2010;89:843\u201350.<\/li><\/ol>
          1. Pollock EM, Ford-Jones EL, Rebeyka I, o.fl. Snemma sj\u00fakrastofus\u00fdkingar hj\u00e1 b\u00f6rnum me\u00f0 hjarta- og \u00e6\u00f0askur\u00f0a\u00f0ger\u00f0ir. Crit Care Med 1990;18:378\u201384.<\/li>
          2. Levy I, Ovadia B, Erez E. Nosocomial s\u00fdkingar eftir hjartaa\u00f0ger\u00f0 hj\u00e1 ungb\u00f6rnum og b\u00f6rnum: t\u00ed\u00f0ni og \u00e1h\u00e6ttu\u00fe\u00e6ttir. J Hosp Infect 2003;53:111\u20136.<\/li>
          3. Allpress AL, Rosenthal GL, Goodrich KM, Lupinetti FM, Zerr DM. \u00c1h\u00e6ttu\u00fe\u00e6ttir fyrir s\u00fdkingar \u00e1 skur\u00f0sv\u00e6\u00f0i eftir hjarta- og \u00e6\u00f0askur\u00f0a\u00f0ger\u00f0ir barna. Pediatr Infect Dis J 2004;23:231\u20134.<\/li><\/ol>
            1. Chan KY, Lau CL, Adeeb SM, Somasundaram S, NasirZahari M. Slembir\u00f6\u00f0u\u00f0, lyfleysu-st\u00fdr\u00f0, tv\u00edblind, tilvonandi kl\u00edn\u00edsk ranns\u00f3kn \u00e1 k\u00edsillgeli til a\u00f0 koma \u00ed veg fyrir ofst\u00e6kkun \u00f6r \u00ed mi\u00f0gildi sternotomy s\u00e1rs. Plast Reconstr Surg 2005;116:1013\u201320.<\/li>
            2. Sakuraba M, Takahashi N, Akahoshi T, Miyasaka Y, Suzuki K. Reynsla af s\u00edlikongelbl\u00f6\u00f0um fyrir sj\u00faklinga me\u00f0 keloid \u00f6r eftir mi\u00f0gildi sternotomy. Gen Thorac Cardiovasc Surg 2010;58:467\u201370.<\/li>
            3. Pai VB, Cummings I. Eru einhverjar g\u00f3\u00f0ar me\u00f0fer\u00f0ir fyrir keloid \u00f6r eftir sternotomy? Interact Cardiovasc Thorac Surg 2011;13:415\u20138.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

              Zip Stitch Longmed Wound Device Slembira\u00f0a\u00f0 ranns\u00f3kn Slembira\u00f0a\u00f0 ranns\u00f3kn \u00e1 n\u00fdjum non-invasive Zip Stitch h\u00fa\u00f0lokunarb\u00fana\u00f0i til notkunar eftir me\u00f0f\u00e6ddar hjartaa\u00f0ger\u00f0ir Yuki Tanaka, l\u00e6knir, Takashi Miyamoto, MD, PhD, Yuji Naito, MD, PhD, Shuichi Yoshitake, MD, MD Sasahara, l\u00e6knir, og Kagami Miyaji, l\u00e6knir, doktorsdeild hjarta- og \u00e6\u00f0askur\u00f0l\u00e6kninga, Gunma barnal\u00e6kningast\u00f6\u00f0,\u2026<\/p>","protected":false},"author":1,"featured_media":689,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"elementor_header_footer","format":"standard","meta":{"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"footnotes":""},"categories":[2],"tags":[41,10,19,28],"class_list":["post-741","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","tag-longmed-skin-closure-device","tag-wound-closure-device","tag-wound-closure-strips-longmed-zip-stitch-emergency-laceration-closures","tag-zip-stitch"],"_links":{"self":[{"href":"https:\/\/longmed-medical.com\/is\/wp-json\/wp\/v2\/posts\/741","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/longmed-medical.com\/is\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/longmed-medical.com\/is\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/longmed-medical.com\/is\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/longmed-medical.com\/is\/wp-json\/wp\/v2\/comments?post=741"}],"version-history":[{"count":0,"href":"https:\/\/longmed-medical.com\/is\/wp-json\/wp\/v2\/posts\/741\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/longmed-medical.com\/is\/wp-json\/wp\/v2\/media\/689"}],"wp:attachment":[{"href":"https:\/\/longmed-medical.com\/is\/wp-json\/wp\/v2\/media?parent=741"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/longmed-medical.com\/is\/wp-json\/wp\/v2\/categories?post=741"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/longmed-medical.com\/is\/wp-json\/wp\/v2\/tags?post=741"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}